MASH WITH FIBROSIS
Clinical trials for MASH WITH FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MASH WITH FIBROSIS trials appear
Sign up with your email to follow new studies for MASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common heart pill treat fatty liver?
Disease control Recruiting nowThis study tests whether a low dose of digoxin, a drug normally used for heart problems, can help people with a severe type of fatty liver disease called NASH (also known as MASH). About 144 adults with confirmed NASH and liver scarring will take digoxin or a placebo for a period…
Matched conditions: MASH WITH FIBROSIS
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 17, 2026 01:49 UTC
-
New drug aims to reverse liver scarring in NASH/MASH patients
Disease control Recruiting nowThis study tests whether efruxifermin can improve or reverse liver scarring in people with NASH/MASH (a type of fatty liver disease) who have moderate fibrosis but not cirrhosis. About 1650 adults will receive either the drug or a placebo for up to several years. The main goals a…
Matched conditions: MASH WITH FIBROSIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated May 05, 2026 11:54 UTC